Full Press Release Details
CAMBRIDGE, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in the following upcoming investor conferences:
Stifel Healthcare Conference
Tuesday, November 14, 2023 at 3:00 p.m. ET (Fireside Chat)
Piper Sandler 35th Annual Healthcare Conference
Thursday November 30, 2023 at 11:00 a.m. ET (Fireside Chat)
A live webcast of each presentation will be available by visiting the "Events and Presentations" section of Fulcrum Therapeutics’ website at https://ir.fulcrumtx.com/events-and-presentations. A replay of the webcasts will be available on Fulcrum Therapeutics’ website for 90 days following each presentation.
About Fulcrum Therapeutics
LifeSci Advisors, LLC